ATECTURA BREEZHALER 150 MCG
INDACATEROL (INDACATEROL ACETATE) : 150 MCG MOMETASONE FUROATE : 320 MCG · DIN 02498693 · NOVARTIS PHARMACEUTICALS CANADA INC
Health Canada status: MARKETED
What is ATECTURA BREEZHALER?
ATECTURA BREEZHALER 150 MCG contains INDACATEROL (INDACATEROL ACETATE) : 150 MCG MOMETASONE FUROATE : 320 MCG. It is listed in the Health Canada Drug Product Database under DIN 02498693, held by NOVARTIS PHARMACEUTICALS CANADA INC, supplied as CAPSULE for INHALATION administration. Health Canada currently lists it as marketed, status dated 19-Aug-2020. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02498693 |
|---|---|
| Brand name | ATECTURA BREEZHALER |
| Generic / active ingredient | INDACATEROL (INDACATEROL ACETATE) : 150 MCG MOMETASONE FUROATE : 320 MCG |
| Manufacturer | NOVARTIS PHARMACEUTICALS CANADA INC |
| Strength | 150 MCG |
| Dosage form | CAPSULE |
| Route of administration | INHALATION |
| Schedule | Prescription |
| ATC code | R03AK14 INDACATEROL AND MOMETASONE |
| AHFS class | 68:04.00 ; 12:12.08.12 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 19-Aug-2020 |
| Original market date | 2020-08-19 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code R03AK14 INDACATEROL AND MOMETASONE. 3 of 3 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ATECTURA BREEZHALER | 150 MCG | CAPSULE | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED | DIN 02498707 |
| ATECTURA BREEZHALER | 80 MCG | CAPSULE | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED | DIN 02498685 |
Who else supplies INDACATEROL AND MOMETASONE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. INDACATEROL AND MOMETASONE appears in 47 registered pack listings across 10 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.